Most Sacred Heart of Jesus Cardiology and Valvular Institute Director Dr. Nalini Rajamannan, has submitted evidence in an open letter to Northwestern University's Newly Minted Vice President for Research Dr. Milan Mrksich, the Senate Finance Committee, the Senate Committee on Homeland Security, the FDA and the NIH providing the evidence of Non-Compliance of the Federal Insurance policy to protect human subjects as it relates to human subject research over the past 14 years including the current clinical trial: Adaptive COVID-19 Treatment Trial.
The COVID-19 Letter is online on Amazon.com (The Myxo Files XXXVI: Covid-19 The Letter):
Dr. Rajamannan is an NIH awardee of the American Recovery and Reinvestment Act, after witnessing the events listed in the letter, she continues her lifelong federal reporting responsibilities under the ARRA funding including the federal code regulations: 46CFR45 and 21CFR50, and 21CFR820.30 to ensure that Northwestern University/ the FDA and the NIH are aware of the non-compliance.
If a device is supposed to get cleared by the agency first before you're marketing it, we consider that investigational, Dr. Jeffrey Shuren, head of the FDA's medical device branch, told The Chicago Tribune in 2011.
The list of violations is as follows:
The patients and the physicians await the FDA's decision to inform the nearly 1000+ patients who unknowingly received the recalled devices the Model 5100, the Model 1155, and the Model 4100.
Request for comment from Northwestern University media affairs office regarding the open letter to the Vice President, resulted in no response to comment on the open letter to the Vice President.
Dr. Nalini Rajamannan is a heart valve expert in the field of cardiovascular medicine. She earned her undergraduate science pre-professional degree from the University of Notre Dame, her Medical Doctorate from Mayo Medical School and her post-graduate training in Internal Medicine and Cardiology at the Mayo Clinic and Research Fellowship on the NIH training Grant. She also worked at the Mayo Clinic as a staff consultant in Internal Medicine and an Associate Professor of Medicine at Northwestern University and the Lakeside and Westside VA. Currently, she practices consultative valvular medicine and Osteocardiology at Most Sacred Heart of Jesus Cardiology and Valvular Institute, WI.
source - https://www.newswire.com/news/dr-rajamannan-reports-to-northwestern-university-chicago-il-vp-covid-21120780
Company Name | Contact Person | Contact Number | Email Id | Website | Address |
---|---|---|---|---|---|
CLINICAL TRAILS.GOV | 3124989496 | heartvalves@sacredcardiology.com | https://clinicaltrials.gov/ |
NutraBio Labs Inc., a dietary supplement manufacturer in Middlesex, NJ, has dedicated part of its GMP manufacturing facility to making an im...Read More
Taking temperature and tracking blood oxygen levels helps individuals with COVID-19 monitor their condition at home or in isolation at the clinic to g...Read More
Celebrity chef Guy Fieri?s bright smile and goatee may have been tucked behind a cloth mask while serving meals to medical staff at Sutter Santa ...Read More
Many states that shared budget projections in response to a new KFF survey of state Medicaid officials report that they expect to see Medica...Read More
The "Impact on Consumer Behavior in the Americas: COVID-19 Survey Snapshot" report has been added to ResearchAndMarkets.com's offering.The publisher i...Read More